iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
Revenue (Most Recent Fiscal Year) | $591.84M |
Net Income (Most Recent Fiscal Year) | $-113.29M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 7.48 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 53.40 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -15.70% |
Net Margin (Trailing 12 Months) | -15.90% |
Return on Equity (Trailing 12 Months) | -101.04% |
Return on Assets (Trailing 12 Months) | -9.55% |
Current Ratio (Most Recent Fiscal Quarter) | 5.71 |
Quick Ratio (Most Recent Fiscal Quarter) | 5.58 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 7.47 |
Inventory Turnover (Trailing 12 Months) | 12.87 |
Book Value per Share (Most Recent Fiscal Quarter) | $2.90 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.95 |
Earnings per Share (Most Recent Fiscal Year) | $-3.08 |
Diluted Earnings per Share (Trailing 12 Months) | $-3.14 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 31.92M |
Free Float | 31.57M |
Market Capitalization | $4.63B |
Average Volume (Last 20 Days) | 0.47M |
Beta (Past 60 Months) | 1.40 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 1.10% |
Percentage Held By Institutions (Latest 13F Reports) | -- |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |